GENinCode (LON:GENI) Sets New 12-Month Low – Should You Sell?

GENinCode Plc (LON:GENIGet Free Report) reached a new 52-week low on Thursday . The company traded as low as GBX 3.10 ($0.04) and last traded at GBX 3.10 ($0.04), with a volume of 50191 shares changing hands. The stock had previously closed at GBX 3.30 ($0.04).

GENinCode Price Performance

The company has a 50-day moving average of GBX 3.86 and a 200 day moving average of GBX 5.23. The company has a debt-to-equity ratio of 9.27, a quick ratio of 15.89 and a current ratio of 2.60. The firm has a market cap of £5.63 million, a P/E ratio of -63.60 and a beta of 0.66.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

See Also

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.